ClinicalTrials.Veeva

Menu

Effect of Sodium Bicarbonate Buffered Lidocaine on the Success of IAN Block of Teeth With Irreversible Pulpitis

M

Masoud Saatchi

Status and phase

Completed
Phase 3

Conditions

Local Anesthesia

Treatments

Drug: placebo
Drug: sodium bicarbonate
Drug: 2% lidocaine with 1:80,000 epinephrine

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Buffering of local anesthetics (alkalinization) has been suggested in achieving pain control. The purpose of this prospective, randomized, double-blind study was to evaluate the effect of adding 0.6 mL 8.4% sodium bicarbonate to 3.0 mL 2% lidocaine with 1: 80,000 epinephrine on the success rate of IAN block for endodontic treatment of mandibular molars with symptomatic irreversible pulpitis.

Full description

Some studies have been shown buffering of local anesthetics reduce pain of injection, hasten the onset of anesthesia, and improved success rate of anesthesia. Others reported buffering of local anesthetics cannot reduce pain of injection, hasten the onset of anesthesia, and improve success rate of anesthesia. There are no studies evaluating a sodium bicarbonate-buffered lidocaine formulation for IAN block for teeth with irreversible pulpitis.

Enrollment

80 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • vital mandibular molar tooth
  • diagnosis of symptomatic irreversible pulpitis

Exclusion criteria

  • younger than 18 years old
  • history of significant medical conditions
  • allergies to local anesthetics or sulfites
  • pregnancy
  • taking any medications that might influence anesthetic assessment
  • active sites of pathosis in area of injection
  • inability to give informed consent

Trial design

80 participants in 2 patient groups

lidocaine & sodium bicarbonate
Experimental group
Description:
2% lidocaine with 1: 80,000 epinephrine buffered with 0.18 mL of 8.4% sodium bicarbonate
Treatment:
Drug: 2% lidocaine with 1:80,000 epinephrine
Drug: sodium bicarbonate
lidocaine & placebo
Active Comparator group
Description:
2% lidocaine with 1:80,000 epinephrine with 0.18 mL of sterile distilled water
Treatment:
Drug: 2% lidocaine with 1:80,000 epinephrine
Drug: placebo

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems